期刊论文详细信息
Frontiers in Pharmacology
Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition
Pharmacology
Xizhe Bai1  Shousheng Xu2  Zhipeng Zeng3  Liqing Zeng3  Bing Han3  Peng Pi3 
[1] College of Physical Education and Health, East China Normal University, Shanghai, China;School of Sports Engineering, Beijing Sport University, Beijing, China;School of Sports Medicine and Rehabilitation, Beijing Sport University, Beijing, China;
关键词: COVID-19;    SARS-CoV-2;    pulmonary fibrosis;    epithelial-mesenchymal transition;    molecular mechanisms;   
DOI  :  10.3389/fphar.2023.1218059
 received in 2023-05-10, accepted in 2023-07-25,  发布年份 2023
来源: Frontiers
PDF
【 摘 要 】

As the outbreak of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first broke out in Hubei Province, China, at the end of 2019. It has brought great challenges and harms to global public health. SARS-CoV-2 mainly affects the lungs and is mainly manifested as pulmonary disease. However, one of the biggest crises arises from the emergence of COVID-19-induced fibrosis. At present, there are still many questions about how COVID-19 induced pulmonary fibrosis (PF) occurs and how to treat and regulate its long-term effects. In addition, as an important process of fibrosis, the effect of COVID-19 on epithelial-mesenchymal transition (EMT) may be an important factor driving PF. This review summarizes the main pathogenesis and treatment mechanisms of COVID-19 related to PF. Starting with the basic mechanisms of PF, such as EMT, transforming growth factor-β (TGF-β), fibroblasts and myofibroblasts, inflammation, macrophages, innate lymphoid cells, matrix metalloproteinases and tissue inhibitors of metalloproteinases, hedgehog pathway as well as Notch signaling. Further, we highlight the importance of COVID-19-induced EMT in the process of PF and provide an overview of the related molecular mechanisms, which will facilitate future research to propose new clinical therapeutic solutions for the treatment of COVID-19-induced PF.

【 授权许可】

Unknown   
Copyright © 2023 Pi, Zeng, Zeng, Han, Bai and Xu.

【 预 览 】
附件列表
Files Size Format View
RO202310109344048ZK.pdf 2200KB PDF download
  文献评价指标  
  下载次数:7次 浏览次数:2次